UBS Group’s DermTech, Inc. Common Stock DMTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,206
| Closed | -$846 | – | 10328 |
|
|
2024
Q1 | $846 | Sell |
1,206
-250
| -17% | -$282 | ﹤0.01% | 8342 |
|
|
2023
Q4 | $2.55K | Sell |
1,456
-1,541
| -51% | -$2.25K | ﹤0.01% | 8095 |
|
|
2023
Q3 | $4.32K | Buy |
2,997
+628
| +27% | +$1.57K | ﹤0.01% | 7451 |
|
|
2023
Q2 | $6.16K | Sell |
2,369
-445
| -16% | -$1.33K | ﹤0.01% | 7390 |
|
|
2023
Q1 | $10.4K | Sell |
2,814
-3,702
| -57% | -$15.6K | ﹤0.01% | 7590 |
|
|
2022
Q4 | $11.5K | Buy |
6,516
+3,191
| +96% | +$8.49K | ﹤0.01% | 8386 |
|
|
2022
Q3 | $13K | Buy |
3,325
+431
| +15% | +$2.65K | ﹤0.01% | 8087 |
|
|
2022
Q2 | $16K | Sell |
2,894
-119,218
| -98% | -$976K | ﹤0.01% | 7226 |
|
|
2022
Q1 | $1.79M | Sell |
122,112
-57,679
| -32% | -$772K | ﹤0.01% | 3538 |
|
|
2021
Q4 | $2.84M | Buy |
179,791
+86,509
| +93% | +$2.08M | ﹤0.01% | 3418 |
|
|
2021
Q3 | $3M | Buy |
93,282
+87,831
| +1,611% | +$3.09M | ﹤0.01% | 3208 |
|
|
2021
Q2 | $226K | Buy |
5,451
+868
| +19% | +$35.7K | ﹤0.01% | 5257 |
|
|
2021
Q1 | $233K | Buy |
4,583
+988
| +27% | +$51.7K | ﹤0.01% | 5373 |
|
|
2020
Q4 | $117K | Buy |
3,595
+2,641
| +277% | +$37.4K | ﹤0.01% | 5585 |
|
|
2020
Q3 | $11K | Sell |
954
-1,626
| -63% | -$18.8K | ﹤0.01% | 6793 |
|
|
2020
Q2 | $34K | Buy |
2,580
+2,570
| +25,700% | +$33.5K | ﹤0.01% | 6193 |
|
|
2020
Q1 | $0 | Sell |
10
-451
| -98% | -$5.54K | ﹤0.01% | 8532 |
|
|
2019
Q4 | $6K | Buy |
+461
| New | +$4.04K | ﹤0.01% | 7543 |
|
|
2019
Q3 | – | Sell |
-90
| Closed | -$2K | – | 8340 |
|
|
2019
Q2 | $2K | Sell |
90
-3,759
| -98% | -$77.1K | ﹤0.01% | 7648 |
|
|
2019
Q1 | $79K | Buy |
3,849
+3,749
| +3,749% | +$76.9K | ﹤0.01% | 5248 |
|
|
2018
Q4 | $2K | Hold |
100
| – | – | ﹤0.01% | 7823 |
|
|
2018
Q3 | $2K | Hold |
100
| – | – | ﹤0.01% | 7763 |
|
|
2018
Q2 | $2K | Hold |
100
| – | – | ﹤0.01% | 7748 |
|
|
2018
Q1 | $2K | Buy |
+100
| New | +$1.96K | ﹤0.01% | 7569 |
|
Other funds holding DMTK
PA
GWSA
T2I
UBS Group's DMTK Position: Q2 2024 in Review
UBS Group sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 1,206 shares — an estimated $846 sold.
UBS Group first reported a position in DMTK in Q1 2018 and held it in 24 quarters. The position peaked at $3M in Q3 2021. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.
- UBS Group reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- UBS Group sold 1,206 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $846.
- UBS Group first reported a position in DermTech, Inc. Common Stock in Q1 2018 and held it in 24 quarters.
- UBS Group's DermTech, Inc. Common Stock position peaked at $3M in Q3 2021.
- 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.